Glycopyrrolate Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single use syringe, NDC: 42852-828-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404
Published March 27, 2019 · Recall initiated: March 13, 2019
Summary
FDA records drug Class II recall D-1021-2019, published March 27, 2019 and initiated March 13, 2019. Recalling firm: Advanced Pharma Inc.; Status: Terminated; Reported quantity: 2580 syringes; Lot: Lot: 12/05/18 0710 82867S Exp. 5/4/2019; 10/24/18 0014 82867S Exp. 3/23/2019; 11/01/18 8800 82867S Exp. 3/31/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Advanced Pharma Inc.
- Distributor
- Nationwide
- Lot
- Lot: 12/05/18 0710 82867S Exp. 5/4/2019; 10/24/18 0014 82867S Exp. 3/23/2019; 11/01/18 8800 82867S Exp. 3/31/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAfentaNYL 1000 mcg/100 mL Injectable Solution Fentanyl 0.9% Sodium Chloride, QS, 100 mL, Sterile single useMarch 27, 2019
- FDAPhenylephrine HCl, 1 mg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution 1 mg/10 mL (100 mcg per mL),March 27, 2019
- FDAMorphine Sulfate 30 mg/30 mL (1 mg/mL) Injectable Solution Morphine Sulfate 30 mg 0.9% Sodium Chloride QS 30March 27, 2019
- FDA2% Lidocaine HCl Injectable Solution, 60 mg/3 mL (20 mg per mL), 3mL Sterile single use syringe, NDC:March 27, 2019
- FDAfentaNYL 2500 mcg/250 mL Injectable Solution, Fentanyl 0.9% Sodium Chloride, QS, Sterile single use bags, NDC:March 27, 2019
- FDAPhenylephrine HCl, 400 mcg in 0.9% Sodium Chloride, QS 10 mL Injectable Solution 400 mcg/10 mL (40 mcg perMarch 27, 2019
Questions about this recall
Was Glycopyrrolate Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single use syringe, NDC: 42852-828-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404 recalled?
Yes. FDA published recall D-1021-2019 on March 27, 2019. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter